Sinopharm
| File:Sinopharm logo.gif | |
| State-owned enterprise (Red chip) | |
| Industry | Pharmaceutical |
| Founded | 2003 |
| Headquarters | Beijing, People's Republic of China |
|
Key people
|
Mr. She Lulin (Chairman) |
| Parent | China National Pharmaceutical Group Corporation |
| Website | Sinopharm Group Company Limited |
Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2015 reached 227 billion RMB ($35 billion USD).[1][2]
Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.
See also
References
External links
- Pages with broken file links
- Pages using infobox company with unsupported parameters
- Hang Seng China Enterprise Index Constitute Stock
- Companies listed on the Hong Kong Stock Exchange
- Companies based in Shanghai
- Government-owned companies of China
- Pharmaceutical companies of China
- Chinese brands
- Fosun International
- Pharmaceutical companies established in 2003
- Retail companies of China
- Warrants issued in Hong Kong Stock Exchange
